BMC Medical Genomics is calling for submissions to our Collection on Newborn screening for genetic disorders.

Newborn screening is a cornerstone of preventive healthcare, enabling the early identification of genetic and metabolic conditions that, if left undetected, can lead to severe health complications or developmental delays. Advances in genomic technologies have transformed the landscape of neonatal diagnostics, allowing for the identification of a wide range of inherited disorders through minimally or non-invasive methods.

By bringing together interdisciplinary work from genomics, pediatrics, public health, and bioethics, this Collection seeks to foster a comprehensive view of how genomic screening can shape the future of neonatal medicine and improve lifelong health trajectories by highlighting research that leverages genomic tools to improve the detection, diagnosis, and understanding of inherited disorders in newborns. We welcome studies that explore rare genetic diseases, evaluate the clinical utility of non-invasive or minimally invasive screening techniques, and investigate the integration of genomic data into neonatal care pathways.

This Collection encourages submissions of original research articles, reviews, methodologies, commentaries, and perspective pieces on topics including, but not limited to:

• Genomic and transcriptomic approaches to newborn screening
• Identification and characterization of rare genetic disorders in neonates
• Non-invasive and minimally invasive screening technologies
• Clinical implementation and diagnostic workflows for genomic screening
• Ethical, regulatory, and policy considerations in neonatal genomics
• Cost-effectiveness and health equity in early genetic testing
• Impact of early diagnosis on long-term health outcomes

This collection supports and amplifies research related to SDG #3: Good Health and Well-Being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Medical Genomics is calling for submissions to our Collection on Genomic characterization of novel resistance mechanisms.

Resistance mechanisms in pathogens pose a significant challenge to effective treatment and disease management. These mechanisms, utilized by a variety of pathogens including bacteria, viruses, fungi, and parasites, lead to resistance against various therapeutic interventions. A deeper understanding and characterization of resistance mechanisms enables more effective medical interventions. It also opens avenues for research into novel intervention options as well as strategies to prevent the development of resistances by more effective utilization of interventions.

The application of genomic technologies has significantly contributed to developing new solutions for tackling resistant pathogens in medicine. By enhancing our ability to identify specific genetic mutations and investigate pathogen-host interactions, these tools have enabled researchers to gain deeper insights into the mechanisms of resistance. This ongoing advancement holds great promise for future targeted therapies.

This Collection aims to highlight research focused on the genomic characterization of novel resistance mechanisms. We invite submissions that explore the integration of genomic data into resistance studies, and the implications for public health and treatment strategies.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.